Skip to main content
. 2016 Jul 13;354:i3625. doi: 10.1136/bmj.i3625

Table 1.

Baseline characteristics of users of non-insulin antidiabetic agents. Values are numbers (percentages) unless stated otherwise

Characteristics Users of non-insulin antidiabetes agents (n=120 803)
Mean (SD) follow-up time 3.65 (2.4)
Women 57 065 (47.2)
Mean (SD) age (years) 67.4 (16.0)
Age group (years):
 18-29 2127 (1.8)
 30-39 4014 (3.3)
 40-49 10 157 (8.4)
 50-59 19 319 (16.0)
 60-69 27 815 (23.0)
 70-79 29 042 (24.0)
 ≥80 28 329 (23.5)
Most recent renal function in past year (mL/min/1.73 m2):
 <30 734 (0.6)
 30-59 19 070 (15.8)
 ≥60 60 025 (49.7)
 Unknown 40 974 (33.9)
Mean (SD) haemoglobin A1c (%) 8.32 (1.86)
Unknown 57 850 (47.9)
Smoking status:
 Current smoker 22 007 (18.2)
 Former smoker 49 598 (41.1)
 Never smoker 48 328 (40.0)
 Unknown 870 (0.7)
Alcohol use:
 Yes 77 880 (64.5)
 No 35 427 (29.3)
 Unknown 7496 (6.2)
Body mass index:
 <20.0 1670 (1.4)
 20.0-24.9 14 759 (12.2)
 25.0-29.9 36 907 (30.6)
 ≥30.0 63 770 (52.8)
 Unknown 3697 (3.1)
History of disease:
 Asthma or COPD 18 698 (15.5)
 Cardiovascular disease 18 863 (15.6)
 Chronic liver disease 321 (0.3)
 Cognitive impairment or dementia 1767 (1.5)
Drug use in past six months:
 Thiazide diuretics 20 689 (17.1)
 RAAS inhibitors 43 611 (36.1)
 Loop diuretics 10 918 (9.0)
 β blockers 20 843 (17.3)
 Calcium channel blockers 23 963 (19.8)
 Typical antipsychotics 1079 (0.9)
 Atypical antipsychotics 1693 (1.4)
 SSRIs 9159 (7.6)
 SNRIs 1491 (1.2)
 Tricyclic antidepressants 7276 (6.0)
 Monoamine oxidase inhibitors 22 (0.02)
 NSAIDs 15 471 (12.8)
 Statins 50 925 (42.2)
 Corticosteroids (systemic) 6185 (5.1)
 Oral anticoagulants 4620 (3.8)
 Trimethoprim 4838 (4.0)

COPD=chronic obstructive pulmonary disease; NSAIDs=non-steroidal anti-inflammatory drugs; RAAS=renin-angiotensin-aldosterone system; SSRIs=selective serotonin reuptake inhibitors; SNRIs=serotonin-norepinephrine reuptake inhibitors.